Position in UTHR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,674,254
-$147,973 QoQ
Shares Held
3,090
+0.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#391
of 870 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $19,819,101 across 9 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
116,275 | $8,355,521 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
47,800 | $8,056,212 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
3,090 | $1,674,254 | |
| 4 | VTRS |
Viatris Inc
|
29,649 | $470,826 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,574 | $324,367 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,757 | $305,861 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
8,973 | $220,825 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
51,052 | $212,376 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,674,254 | 3,090 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,822,227 | 3,073 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,557,251 | 3,196 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,800,087 | 4,294 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,378,130 | 4,796 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,383,515 | 4,488 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,646,704 | 4,667 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,238,970 | 6,248 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,646,903 | 5,170 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,065,900 | 4,640 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $866,586 | 3,941 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $776,089 | 3,436 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,608,384 | 7,286 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,470,073 | 6,564 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,008,644 | 7,223 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,944,512 | 9,287 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,549,097 | 6,574 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $595,282 | 3,318 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $802,521 | 3,714 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $651,567 | 3,530 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $513,112 | 2,860 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $514,187 | 3,074 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $407,100 | 2,682 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $274,316 | 2,716 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $641,058 | 5,298 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||